Spectral AI Receives FDA De Novo Clearance for DeepView Burn Assessment System

Spectral AI's DeepView System, an AI-powered medical device for burn wound assessment, received FDA De Novo classification, authorizing commercial distribution in the U.S. The clearance enables the company to commercialize its non-invasive diagnostic technology across burn centers, trauma centers, and emergency departments.